 | • レポートコード：QYR9ST01128 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界のパーキンソン病薬市場について調査・分析し、以下の構成でお届け致します。パーキンソン病薬の種類別には、カルビドパ/レボドパ、ドーパミン受容体アゴニスト、MAO阻害剤に、用途別には、病院、オンライン、小売薬局に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別パーキンソン病薬売上データ ・地域別パーキンソン病薬市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別パーキンソン病薬市場規模：カルビドパ/レボドパ、ドーパミン受容体アゴニスト、MAO阻害剤 ・用途別パーキンソン病薬市場規模：病院、オンライン、小売薬局 ・主要メーカーの企業情報：Teva、Novartis AG、GSK、AbbVie、Merck、Boehringer Ingelheim、Impax Laboratories、Lundbeck、Sun Pharma、Wockhardt、UCB、Valeant Pharmaceuticals、Acadia ・パーキンソン病薬の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Researchers are working to develop new and improved therapies for people with Parkinson’s disease (PD). There have been many drugs that have been approved to treat Parkinson disease.The global Parkinsons disease Drug market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Parkinsons disease Drug market based on company, product type, end user and key regions.
This report studies the global market size of Parkinsons disease Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Parkinsons disease Drug in these regions.
This research report categorizes the global Parkinsons disease Drug market by top players/brands, region, type and end user. This report also studies the global Parkinsons disease Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Teva
Novartis AG
GSK
AbbVie
Merck
Boehringer Ingelheim
Impax Laboratories
Lundbeck
Sun Pharma
Wockhardt
UCB
Valeant Pharmaceuticals
Acadia
Market size by Product
Carbidopa/Levodopa
Dopamine Receptor Agonists
MAO-Inhibitors
Market size by End User
Hospital
Online
Retail Pharmacies
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Parkinsons disease Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Parkinsons disease Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Parkinsons disease Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Parkinsons disease Drug submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Parkinsons disease Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Parkinsons disease Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Parkinsons disease Drug Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Parkinsons disease Drug Market Size Growth Rate by Product
1.4.2 Carbidopa/Levodopa
1.4.3 Dopamine Receptor Agonists
1.4.4 MAO-Inhibitors
1.5 Market by End User
1.5.1 Global Parkinsons disease Drug Market Size Growth Rate by End User
1.5.2 Hospital
1.5.3 Online
1.5.4 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Parkinsons disease Drug Market Size
2.1.1 Global Parkinsons disease Drug Revenue 2014-2025
2.1.2 Global Parkinsons disease Drug Sales 2014-2025
2.2 Parkinsons disease Drug Growth Rate by Regions
2.2.1 Global Parkinsons disease Drug Sales by Regions
2.2.2 Global Parkinsons disease Drug Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Parkinsons disease Drug Sales by Manufacturers
3.1.1 Parkinsons disease Drug Sales by Manufacturers
3.1.2 Parkinsons disease Drug Sales Market Share by Manufacturers
3.1.3 Global Parkinsons disease Drug Market Concentration Ratio (CR5 and HHI)
3.2 Parkinsons disease Drug Revenue by Manufacturers
3.2.1 Parkinsons disease Drug Revenue by Manufacturers (2014-2019)
3.2.2 Parkinsons disease Drug Revenue Share by Manufacturers (2014-2019)
3.3 Parkinsons disease Drug Price by Manufacturers
3.4 Parkinsons disease Drug Manufacturing Base Distribution, Product Types
3.4.1 Parkinsons disease Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Parkinsons disease Drug Product Type
3.4.3 Date of International Manufacturers Enter into Parkinsons disease Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Parkinsons disease Drug Sales by Product
4.2 Global Parkinsons disease Drug Revenue by Product
4.3 Parkinsons disease Drug Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Parkinsons disease Drug Breakdown Data by End User
6 North America
6.1 North America Parkinsons disease Drug by Countries
6.1.1 North America Parkinsons disease Drug Sales by Countries
6.1.2 North America Parkinsons disease Drug Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Parkinsons disease Drug by Product
6.3 North America Parkinsons disease Drug by End User
7 Europe
7.1 Europe Parkinsons disease Drug by Countries
7.1.1 Europe Parkinsons disease Drug Sales by Countries
7.1.2 Europe Parkinsons disease Drug Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Parkinsons disease Drug by Product
7.3 Europe Parkinsons disease Drug by End User
8 Asia Pacific
8.1 Asia Pacific Parkinsons disease Drug by Countries
8.1.1 Asia Pacific Parkinsons disease Drug Sales by Countries
8.1.2 Asia Pacific Parkinsons disease Drug Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Parkinsons disease Drug by Product
8.3 Asia Pacific Parkinsons disease Drug by End User
9 Central & South America
9.1 Central & South America Parkinsons disease Drug by Countries
9.1.1 Central & South America Parkinsons disease Drug Sales by Countries
9.1.2 Central & South America Parkinsons disease Drug Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Parkinsons disease Drug by Product
9.3 Central & South America Parkinsons disease Drug by End User
10 Middle East and Africa
10.1 Middle East and Africa Parkinsons disease Drug by Countries
10.1.1 Middle East and Africa Parkinsons disease Drug Sales by Countries
10.1.2 Middle East and Africa Parkinsons disease Drug Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Parkinsons disease Drug by Product
10.3 Middle East and Africa Parkinsons disease Drug by End User
11 Company Profiles
11.1 Teva
11.1.1 Teva Company Details
11.1.2 Company Business Overview
11.1.3 Teva Parkinsons disease Drug Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Teva Parkinsons disease Drug Products Offered
11.1.5 Teva Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Details
11.2.2 Company Business Overview
11.2.3 Novartis AG Parkinsons disease Drug Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Novartis AG Parkinsons disease Drug Products Offered
11.2.5 Novartis AG Recent Development
11.3 GSK
11.3.1 GSK Company Details
11.3.2 Company Business Overview
11.3.3 GSK Parkinsons disease Drug Sales, Revenue and Gross Margin (2014-2019)
11.3.4 GSK Parkinsons disease Drug Products Offered
11.3.5 GSK Recent Development
11.4 AbbVie
11.4.1 AbbVie Company Details
11.4.2 Company Business Overview
11.4.3 AbbVie Parkinsons disease Drug Sales, Revenue and Gross Margin (2014-2019)
11.4.4 AbbVie Parkinsons disease Drug Products Offered
11.4.5 AbbVie Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Company Business Overview
11.5.3 Merck Parkinsons disease Drug Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Merck Parkinsons disease Drug Products Offered
11.5.5 Merck Recent Development
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Details
11.6.2 Company Business Overview
11.6.3 Boehringer Ingelheim Parkinsons disease Drug Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Boehringer Ingelheim Parkinsons disease Drug Products Offered
11.6.5 Boehringer Ingelheim Recent Development
11.7 Impax Laboratories
11.7.1 Impax Laboratories Company Details
11.7.2 Company Business Overview
11.7.3 Impax Laboratories Parkinsons disease Drug Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Impax Laboratories Parkinsons disease Drug Products Offered
11.7.5 Impax Laboratories Recent Development
11.8 Lundbeck
11.8.1 Lundbeck Company Details
11.8.2 Company Business Overview
11.8.3 Lundbeck Parkinsons disease Drug Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Lundbeck Parkinsons disease Drug Products Offered
11.8.5 Lundbeck Recent Development
11.9 Sun Pharma
11.9.1 Sun Pharma Company Details
11.9.2 Company Business Overview
11.9.3 Sun Pharma Parkinsons disease Drug Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Sun Pharma Parkinsons disease Drug Products Offered
11.9.5 Sun Pharma Recent Development
11.10 Wockhardt
11.10.1 Wockhardt Company Details
11.10.2 Company Business Overview
11.10.3 Wockhardt Parkinsons disease Drug Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Wockhardt Parkinsons disease Drug Products Offered
11.10.5 Wockhardt Recent Development
11.11 UCB
11.12 Valeant Pharmaceuticals
11.13 Acadia
12 Future Forecast
12.1 Parkinsons disease Drug Market Forecast by Regions
12.1.1 Global Parkinsons disease Drug Sales Forecast by Regions 2019-2025
12.1.2 Global Parkinsons disease Drug Revenue Forecast by Regions 2019-2025
12.2 Parkinsons disease Drug Market Forecast by Product
12.2.1 Global Parkinsons disease Drug Sales Forecast by Product 2019-2025
12.2.2 Global Parkinsons disease Drug Revenue Forecast by Product 2019-2025
12.3 Parkinsons disease Drug Market Forecast by End User
12.4 North America Parkinsons disease Drug Forecast
12.5 Europe Parkinsons disease Drug Forecast
12.6 Asia Pacific Parkinsons disease Drug Forecast
12.7 Central & South America Parkinsons disease Drug Forecast
12.8 Middle East and Africa Parkinsons disease Drug Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Parkinsons disease Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Parkinsons disease Drug Product Picture
Table Parkinsons disease Drug Market Segments
Table Key Manufacturers Parkinsons disease Drug Covered
Table Global Parkinsons disease Drug Market Size Growth Rate by Product 2019-2025 (K Doses) & (Million US$)
Figure Global Parkinsons disease Drug Sales Market Share by Product 2014-2025
Figure Carbidopa/Levodopa Product Picture
Table Major Manufacturers of Carbidopa/Levodopa
Figure Dopamine Receptor Agonists Product Picture
Table Major Manufacturers of Dopamine Receptor Agonists
Figure MAO-Inhibitors Product Picture
Table Major Manufacturers of MAO-Inhibitors
Table Global Parkinsons disease Drug Market Size Growth Rate by End User 2019-2025 (K Doses)
Figure Hospital
Figure Online
Figure Retail Pharmacies
Figure Parkinsons disease Drug Report Years Considered
Figure Global Parkinsons disease Drug Market Size 2014-2025 (Million US$)
Figure Global Parkinsons disease Drug Sales 2014-2025 (K Doses)
Table Global Parkinsons disease Drug Market Size by Regions 2014-2019 (K Doses) & (Million US$)
Table Global Parkinsons disease Drug Sales by Regions 2014-2019 (K Doses)
Table Global Parkinsons disease Drug Sales Market Share by Regions 2014-2019
Figure Global Parkinsons disease Drug Sales Market Share by Regions 2014-2019
Figure 2018 Global Parkinsons disease Drug Sales Market Share by Regions
Table Global Parkinsons disease Drug Revenue by Regions 2014-2019 (Million US$)
Table Global Parkinsons disease Drug Revenue Market Share by Regions 2014-2019
Figure Global Parkinsons disease Drug Revenue Market Share by Regions 2014-2019
Figure 2018 Global Parkinsons disease Drug Revenue Market Share by Regions
Table Global Parkinsons disease Drug Sales by Manufacturers (2014-2019) (K Doses)
Table Global Parkinsons disease Drug Sales Share by Manufacturers (2014-2019)
Figure Global Parkinsons disease Drug Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Parkinsons disease Drug Revenue by Manufacturers (2014-2019) (Million USD)
Table Parkinsons disease Drug Revenue Share by Manufacturers (2014-2019)
Figure Parkinsons disease Drug Value Share by Manufacturers in 2018
Table Key Manufacturers Parkinsons disease Drug Price (2014-2019) (USD/Dose)
Table Parkinsons disease Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Parkinsons disease Drug Product Type
Table Date of International Manufacturers Enter into Parkinsons disease Drug Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Parkinsons disease Drug Sales by Product (2014-2019) (K Doses)
Table Global Parkinsons disease Drug Sales Share by Product (2014-2019)
Figure Global Parkinsons disease Drug Sales Market Share by Product (2014-2019)
Figure Global Parkinsons disease Drug Sales Market Share by Product in 2018
Table Global Parkinsons disease Drug Revenue by Product (2014-2019) (Million US$)
Table Global Parkinsons disease Drug Revenue Share by Product (2014-2019)
Figure Global Parkinsons disease Drug Revenue Market Share by Product (2014-2019)
Figure Global Parkinsons disease Drug Revenue Market Share by Product in 2018
Table Parkinsons disease Drug Price by Product 2014-2019 (USD/Dose)
Table Global Parkinsons disease Drug Sales by End User (2014-2019) (K Doses)
Table Global Parkinsons disease Drug Sales Share by End User (2014-2019)
Figure Global Sales Parkinsons disease Drug Market Share by End User (2014-2019)
Figure Global Sales Parkinsons disease Drug Market Share by End User in 2018
Figure North America Parkinsons disease Drug Sales Growth Rate 2014-2019 (K Doses)
Figure North America Parkinsons disease Drug Revenue Growth Rate 2014-2019 (Million US$)
Table North America Parkinsons disease Drug Sales by Countries (2014-2019) (K Doses)
Table North America Parkinsons disease Drug Sales Market Share by Countries (2014-2019)
Figure 2018 North America Parkinsons disease Drug Sales Market Share by Countries
Table North America Parkinsons disease Drug Revenue by Countries (2014-2019) (Million US$)
Table North America Parkinsons disease Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Parkinsons disease Drug Revenue Market Share by Countries
Figure United States Parkinsons disease Drug Sales Growth Rate (2014-2019) (K Doses)
Figure United States Parkinsons disease Drug Revenue Growth Rate (2014-2019) (K Doses)
Figure Canada Parkinsons disease Drug Sales Growth Rate (2014-2019) (K Doses)
Figure Canada Parkinsons disease Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Parkinsons disease Drug Sales Growth Rate (2014-2019) (K Doses)
Figure Mexico Parkinsons disease Drug Revenue Growth Rate (2014-2019) (Million US$)
Table North America Parkinsons disease Drug Sales by Product (2014-2019) (K Doses)
Table North America Parkinsons disease Drug Sales Market Share by Product (2014-2019)
Figure 2018 North America Parkinsons disease Drug Market Share by Product
Table North America Parkinsons disease Drug Sales by End User (2014-2019) (K Doses)
Table North America Parkinsons disease Drug Sales Market Share by End User (2014-2019)
Figure 2018 North America Parkinsons disease Drug Market Share by End User
Figure Europe Parkinsons disease Drug Sales Growth Rate 2014-2019 (K Doses)
Figure Europe Parkinsons disease Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Parkinsons disease Drug Sales by Countries (2014-2019) (K Doses)
Table Europe Parkinsons disease Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Parkinsons disease Drug Sales Market Share by Countries
Table Europe Parkinsons disease Drug Revenue by Countries (2014-2019) (Million US$)
Table Europe Parkinsons disease Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Parkinsons disease Drug Revenue Market Share by Countries
Figure Germany Parkinsons disease Drug Sales Growth Rate (2014-2019) (K Doses)
Figure Germany Parkinsons disease Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure France Parkinsons disease Drug Sales Growth Rate (2014-2019) (K Doses)
Figure France Parkinsons disease Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Parkinsons disease Drug Sales Growth Rate (2014-2019) (K Doses)
Figure UK Parkinsons disease Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Parkinsons disease Drug Sales Growth Rate (2014-2019) (K Doses)
Figure Italy Parkinsons disease Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Parkinsons disease Drug Sales Growth Rate (2014-2019) (K Doses)
Figure Russia Parkinsons disease Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Parkinsons disease Drug Sales by Product (2014-2019) (K Doses)
Table Europe Parkinsons disease Drug Sales Market Share by Product (2014-2019)
Figure 2018 Europe Parkinsons disease Drug Market Share by Product
Table Europe Parkinsons disease Drug Sales by End User (2014-2019) (K Doses)
Table Europe Parkinsons disease Drug Sales Market Share by End User (2014-2019)
Figure 2018 Europe Parkinsons disease Drug Market Share by End User
Figure Asia Pacific Parkinsons disease Drug Sales Growth Rate 2014-2019 (K Doses)
Figure Asia Pacific Parkinsons disease Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Parkinsons disease Drug Sales by Countries (2014-2019) (K Doses)
Table Asia Pacific Parkinsons disease Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Parkinsons disease Drug Sales Market Share by Countries
Table Asia Pacific Parkinsons disease Drug Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Parkinsons disease Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Parkinsons disease Drug Revenue Market Share by Countries
Figure China Parkinsons disease Drug Sales Growth Rate (2014-2019) (K Doses)
Figure China Parkinsons disease Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Parkinsons disease Drug Sales Growth Rate (2014-2019) (K Doses)
Figure Japan Parkinsons disease Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Parkinsons disease Drug Sales Growth Rate (2014-2019) (K Doses)
Figure Korea Parkinsons disease Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure India Parkinsons disease Drug Sales Growth Rate (2014-2019) (K Doses)
Figure India Parkinsons disease Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Parkinsons disease Drug Sales Growth Rate (2014-2019) (K Doses)
Figure Australia Parkinsons disease Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Parkinsons disease Drug Sales Growth Rate (2014-2019) (K Doses)
Figure Indonesia Parkinsons disease Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Parkinsons disease Drug Sales Growth Rate (2014-2019) (K Doses)
Figure Malaysia Parkinsons disease Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Parkinsons disease Drug Sales Growth Rate (2014-2019) (K Doses)
Figure Philippines Parkinsons disease Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Parkinsons disease Drug Sales Growth Rate (2014-2019) (K Doses)
Figure Thailand Parkinsons disease Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Parkinsons disease Drug Sales Growth Rate (2014-2019) (K Doses)
Figure Vietnam Parkinsons disease Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Parkinsons disease Drug Sales Growth Rate (2014-2019) (K Doses)
Figure Singapore Parkinsons disease Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Parkinsons disease Drug Sales by Product (2014-2019) (K Doses)
Table Asia Pacific Parkinsons disease Drug Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Parkinsons disease Drug Market Share by Product
Table Asia Pacific Parkinsons disease Drug Sales by End User (2014-2019) (K Doses)
Table Asia Pacific Parkinsons disease Drug Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Parkinsons disease Drug Market Share by End User
Figure Central & South America Parkinsons disease Drug Sales Growth Rate 2014-2019 (K Doses)
Figure Central & South America Parkinsons disease Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Parkinsons disease Drug Sales by Countries (2014-2019) (K Doses)
Table Central & South America Parkinsons disease Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Parkinsons disease Drug Sales Market Share by Countries
Table Central & South America Parkinsons disease Drug Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Parkinsons disease Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Parkinsons disease Drug Revenue Market Share by Countries
Figure Brazil Parkinsons disease Drug Sales Growth Rate (2014-2019) (K Doses)
Figure Brazil Parkinsons disease Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Parkinsons disease Drug Sales Growth Rate (2014-2019) (K Doses)
Figure Argentina Parkinsons disease Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Parkinsons disease Drug Sales by Product (2014-2019) (K Doses)
Table Central & South America Parkinsons disease Drug Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Parkinsons disease Drug Market Share by Product
Table Central & South America Parkinsons disease Drug Sales by End User (2014-2019) (K Doses)
Table Central & South America Parkinsons disease Drug Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Parkinsons disease Drug Market Share by End User
Figure Middle East and Africa Parkinsons disease Drug Sales Growth Rate 2014-2019 (K Doses)
Figure Middle East and Africa Parkinsons disease Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Parkinsons disease Drug Sales by Countries (2014-2019) (K Doses)
Table Middle East and Africa Parkinsons disease Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Parkinsons disease Drug Sales Market Share by Countries
Table Middle East and Africa Parkinsons disease Drug Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Parkinsons disease Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Parkinsons disease Drug Revenue Market Share by Countries
Figure GCC Countries Parkinsons disease Drug Sales Growth Rate (2014-2019) (K Doses)
Figure GCC Countries Parkinsons disease Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Parkinsons disease Drug Sales Growth Rate (2014-2019) (K Doses)
Figure Turkey Parkinsons disease Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Parkinsons disease Drug Sales Growth Rate (2014-2019) (K Doses)
Figure Egypt Parkinsons disease Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Parkinsons disease Drug Sales Growth Rate (2014-2019) (K Doses)
Figure South Africa Parkinsons disease Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Parkinsons disease Drug Sales by Product (2014-2019) (K Doses)
Table Middle East and Africa Parkinsons disease Drug Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Parkinsons disease Drug Market Share by Product
Table Middle East and Africa Parkinsons disease Drug Sales by End User (2014-2019) (K Doses)
Table Middle East and Africa Parkinsons disease Drug Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Parkinsons disease Drug Market Share by End User
Table Teva Company Details
Table Teva Parkinsons disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Teva Recent Development
Table Novartis AG Company Details
Table Novartis AG Parkinsons disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Novartis AG Recent Development
Table GSK Company Details
Table GSK Parkinsons disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table GSK Recent Development
Table AbbVie Company Details
Table AbbVie Parkinsons disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table AbbVie Recent Development
Table Merck Company Details
Table Merck Parkinsons disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Merck Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Parkinsons disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Impax Laboratories Company Details
Table Impax Laboratories Parkinsons disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Impax Laboratories Recent Development
Table Lundbeck Company Details
Table Lundbeck Parkinsons disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Lundbeck Recent Development
Table Sun Pharma Company Details
Table Sun Pharma Parkinsons disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Sun Pharma Recent Development
Table Wockhardt Company Details
Table Wockhardt Parkinsons disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Wockhardt Recent Development
Table UCB Company Details
Table Valeant Pharmaceuticals Company Details
Table Acadia Company Details
Table Global Parkinsons disease Drug Sales Forecast by Regions 2019-2025 (K Doses)
Table Global Parkinsons disease Drug Sales Market Share Forecast by Regions 2019-2025
Table Global Parkinsons disease Drug Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Parkinsons disease Drug Revenue Market Share Forecast by Regions 2019-2025
Table Global Parkinsons disease Drug Sales Forecast by Product 2019-2025 (K Doses)
Table Global Parkinsons disease Drug Sales Market Share Forecast by Product 2019-2025
Table Global Parkinsons disease Drug Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Parkinsons disease Drug Revenue Market Share Forecast by Product 2019-2025
Table Global Parkinsons disease Drug Sales Forecast by End User 2019-2025 (K Doses)
Table Global Parkinsons disease Drug Sales Market Share Forecast by End User 2019-2025
Figure North America Parkinsons disease Drug Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure North America Parkinsons disease Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Parkinsons disease Drug Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Europe Parkinsons disease Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Parkinsons disease Drug Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Asia Pacific Parkinsons disease Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Parkinsons disease Drug Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Central & South America Parkinsons disease Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Parkinsons disease Drug Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Middle East and Africa Parkinsons disease Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Parkinsons disease Drug Value Chain
Table Parkinsons disease Drug Customers List
Table Parkinsons disease Drug Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界のベーチェット病治療薬市場：専門的調査 The global Behcet Disease Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Behcet Disease Drug volume and value at global level, regional level and company level. From a global perspective, this…- パーキンソン病治療の世界市場：市場規模・現状・予測 Parkinson's disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system.There is no cure for Parkinson's disease, with treatment directed at improving symptoms. Initial treatment is typically with the antiparkinson medication levodopa (L-DOPA)…
- セリアック病の世界市場：インサイト・予測 Celiac disease is a serious autoimmune disorder that can occur in genetically predisposed people where the ingestion of gluten leads to damage in the small intestine. It is estimated to affect 1 in 100 people worldwide.The global Celiac Disease market is valued at 130 million US$ in 2018 and will re…
- アルツハイマー病患者の世界市場：インサイト・予測 Alzheimer’s is a complex disease，though many marketed drugs have been approved for Alzheimer’s disease, but it still remains a significant area of unmet medical need. Currently there’s no cure for Alzheimer’s and its still waiting for its key product, numerous companies are developing novel treatmen…
- 全身性エリテマトーデスSLE治療薬の世界市場：インサイト・予測 Systemic Lupus Erythematous SLE Drug is an autoimmune disease involving multiple systems, multiple organs, and multiple autoantibodies.The global Systemic Lupus Erythematous SLE Drug market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx%…